A switch to dactinomycin: what is the cutoff value for hCG?
Journal
BJOG: An International Journal of Obstetrics and Gynaecology
Journal Volume
127
Journal Issue
9
Pages
1146
Date Issued
2020
Author(s)
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
SDGs
Other Subjects
chorionic gonadotropin; dactinomycin; methotrexate; chorionic gonadotropin; dactinomycin; methotrexate; cancer chemotherapy; cancer risk; drug efficacy; human; Note; priority journal; relapse; treatment duration; treatment failure; trophoblastic tumor; female; pregnancy; retrospective study; risk factor; trophoblastic tumor; Chorionic Gonadotropin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Risk Factors
Publisher
Blackwell Publishing Ltd
Type
note